Results 141 to 150 of about 9,756 (290)

Refractory episodic vertigo: role of intratympanic gentamicin and vestibular evoked myogenic potentials,

Brazilian Journal of Otorhinolaryngology
Introduction: Even today, the treatment of intractable vertigo remains a challenge. Vestibular ablation with intratympanic gentamicin stands as a good alternative in the management of refractory vertigo patients.
Erika Celis-Aguilar, Ramon Hinojosa-González, Olivia Vales-Hidalgo, Heloisa Coutinho-Toledo   +3 more
doaj   +1 more source

Effects of Intratympanic Injection of Isosorbide on the Vestibular Function of Animal Models of Endolymphatic Hydrops [PDF]

, 2020
Minbum Kim, So Yeon Yoon, Hansol Hong, Hyun Jun Hong   +3 more
openalex   +1 more source

Comparison of the Protective Efficacy of Intratympanic Oxytocin and Dexamethasone in Cisplatin-induced Ototoxicity [PDF]

, 2022
Burak Mustafa Taş, Gökçe Şimşek, Musa Azman, Isil Karaer, Rahmi Kılıç   +4 more
openalex   +1 more source

Clinical effect of intratympanic dexamethasone injection in acute unilateral tinnitus: A prospective, placebo‐controlled, multicenter study

, 2017
Hyun‐Jin Lee, Min‐Beom Kim, Shin‐Young Yoo, Shi Nae Park, Eui‐Cheol Nam, In Seok Moon, Ho‐Ki Lee   +6 more
openalex   +2 more sources

Intratympanic Gentamicin Treatment for Ménière’s Disease

, 2019
Yongchuan Chai, Hongzhe Li
openalex   +2 more sources

Intratympanic Gentamicin Injection for Endolymphatic Hydrops After Cochlear Implantation

Journal of International Advanced Otology
Endolymphatic hydrops has been documented as a possible complication of cochlear implantation; however, few studies have addressed its treatment.
Pietro Canzi, Elena Carlotto, Silvia Quaglieri, Maurizio Guida, Domenico Minervini, Ilaria Ottoboni, Cesare Chiapperini, Anna Chiara Stellato, Marco Lucio Manfrin, Marco Benazzo   +9 more
doaj   +1 more source

Dependence of Hearing Changes on the Dose of Intratympanically Applied Gentamicin: A Meta‐Analysis Using Mathematical Simulations of Clinical Drug Delivery Protocols

, 2008
Alec N. Salt, Ruth Gill, Stefan K. Plontke   +2 more
openalex   +2 more sources

Intratympanic aminoglycosides for Ménière’s disease

, 2023
Background Ménière's disease is a condition that causes recurrent episodes of vertigo, associated with hearing loss and tinnitus. Aminoglycosides are sometimes administered directly into the middle ear to treat this condition. The aim of this treatment is to partially or completely destroy the balance function of the affected ear.
Webster, K, Galbraith, K, Lee, A, MacKeith, S, Burton, M   +4 more
openaire   +1 more source

Dynamics of endolymphatic hydrops according to magnetic resonance imaging of the inner ear after drainage of the endolymphatic sac

Consilium Medicum
Background. Ménière's disease is a multifactorial disease characterized by recurrent dizziness, fluctuating hearing changes, congestion and noise in the ear.
Valery M. Svistushkin, Svetlana V. Starostina, Isa T. Muhamedov, Elena A. Stepanova, Darima B. Bidanova   +4 more
doaj   +1 more source

Efficacy of a combined drug therapy for ameliorating noise-induced hearing loss [PDF]

, 2011
Experiments investigated the median effective dose of antiepileptic drugs and synthetic glucocorticoids for the prevention and treatment of noise-induced hearing loss for C57BL/6J mice.
Luxmore, Randi Lynn
core   +1 more source